Companies · Other Health Care

Alchera Inc

WALNUT CREEK · Other Health Care

Diligence memoA one-page analyst read on Alchera Inc — recommendation, valuation, rhythm, risks.
$13.4M
Total raised · real
3
Rounds
0.9×
Latest step-up
Top 22%
Sector rank · raised
Series A
Latest stage · inferred · Thu Oct 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Alchera Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.65× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
  • Issuer reports $1M–$5M revenue while modeled below niche peers.
Dormant
  • Last raise 4.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Alchera Inc is one of 5377 Other Health Care companies tracked from WALNUT CREEK. By capital raised it ranks in the upper tier (ahead of 79% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$1M–$5M
Issuer revenue
Rule 506(c)
Reg D exemption
56
Investors (latest)
2021-10-28
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2012-09-17 Raised $1.2M (real) Modeled valuation $30M (est)$1.2M$30MSeed2012Seed · 2012-09-17 Raised $2.5M (real) Modeled valuation $61M (est)$2.5M$61MSeed2012Series A · 2013-10-15 Raised $5.7M (real) Modeled valuation $115M (est)$5.7M$115MSeries A2013Series A · 2021-10-28 Raised $5.2M (real) Modeled valuation $65M (est)$5.2M$65MSeries A2021+$2.5M+$5.7M+$5.2MCumulative $15M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.2M · 2012
Seed extension$2.5M · 2012
Series A$5.7M · 2013
Series A extension$5.2M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$65.3M
Base estimate est.
$6.7M
Conservative case
$261.8M
Upside case
$23.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $30.1M · 2012-09-172012Seed · modeled $61.4M · 2012-09-17Series A · modeled $115.0M · 2013-10-15Series A · modeled $65.3M · 2021-10-282021
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
4.7 yr
Elapsed time used
4.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
36 mo
Avg between rounds
$1.5M/yr
Capital velocity
13.8 yr
On record since
2012
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.5× above median
This company$13.4M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.9× of median
This company$5.2M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 3.0× above median
This company$65.3M
Sector median$22.1M

Raised more than 79% of sector peers (real $). Modeled value above 71% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #127 of 164.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $260.0M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.6M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.3M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.5M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)Alchera Inc (this company) Raised $13.4M · modeled $65.3M (est)Alchera Inc
CompanyStageRaised · realValue · estvs peer med.
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$260.0M2.58×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.6M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.3M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.5M2.20×
Zipari, Inc.Series A$29.6M$208.3M2.06×
Alchera Inc this companySeries A$13.4M$65.3M0.65×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.2M2012-09-17$6.1M$30.1M85%
Seed$2.5M2012-09-17$12.4M$61.4M85%
Series A$5.7M2013-10-15$25.9M$115.0M90%
Series A$5.2M2021-10-28$23.6M$65.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.2M2012-09-17
    • First recorded raise — entered as Seed.
    • 31 investors on this round.
  2. Seed$2.5M2012-09-17
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
    • Switched to Rule 505 (was Rule 06).
    • 48 investors on this round.
  3. Series A$5.7M2013-10-15
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 505).
    • 60 investors on this round.
  4. Series A$5.2M2021-10-28
    • Raised again after 96 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Revenue band moved $0–$1M → $1M–$5M.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 56 investors on this round.
Intelligence
2024 ~Q4
Modeled next raise · ~36mo cadence
$5.2M
Modeled next size est.range $5.2M$8.3M
0.9×
Last step-up
$1.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Lester John Lloyd2 other2012-09
Andrew Thomas Lloyd1 other2012-09
Lester J Lloyd1 other2021-10
Donald J Shirley2021-10
Donald Thomas Shirley2013-10
Esben J Dissing-Immerkaer2021-10
James J Mitchell2021-10
Kenneth Thomas Traverso2012-09
Kenneth Traverso2021-10
Ken Thomas Traverso2013-10
Merwin J Hansen2012-09
Timothy Patrick Lloyd2012-09
Wende J Hutton2021-10
Registry & provenance

Alchera Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1559079
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
CARDIOX CorpOther Health CareSeries A$13.5M$63.8Msame sector · same stage
CytoAgents, Inc.Other Health CareSeries A$13.1M$51.2Msame sector · same stage
valisure llcOther Health CareSeries A$12.6M$76.5Msame sector · same stage
Vibrynt, INcOther Health CareSeries A$14.3M$55.5Msame sector · same stage
Learn to Live, Inc.Other Health CareSeries A$14.3M$63.7Msame sector · same stage
ViroCyt, LLCOther Health CareSeries A$14.3M$70.0Msame sector · same stage
H-Cyte, Inc.Other Health CareSeries A$14.6M$58.1Msame sector · same stage
Elenza, IncOther Health CareSeries A$14.6M$67.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
ALM Ortho IncOther Health CarePre-Seed$579K85%
Algorics Inc.Other Health CareSeed$17.3M85%
Alacura Holdings, Inc.Other Health CareSeries A$15.6M83%
Arthroba, Inc.Other Health CarePre-Seed$2.4M82%
Alcyone Lifesciences, Inc.Other Health CareSeries B$151.7M82%
Alveo Investments, LLCOther Health CareSeed$13.0M82%
Osheru, Inc.Other Health CareSeries A$15.0M82%
AbriCare, Inc.Other Health CareSeries A$39.1M82%
Frequently asked
How much funding has Alchera Inc raised?
Alchera Inc has raised approximately $13.4M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Alchera Inc's estimated valuation?
Provath's modeled valuation for Alchera Inc is approximately $65.3M (modeled range $6.7M–$261.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Alchera Inc at?
Alchera Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Oct 28.
What does Alchera Inc do and where is it based?
Alchera Inc operates in the Other Health Care sector, based in WALNUT CREEK.
Explore related

See where Alchera Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Alchera Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.